Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Liang

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Cancer Genetics and Cytogenetics|May 1, 1994
5q- chromosome. Evidence for complex interstitial breaks in a case of refractory anemia with excess blastsL Nagarajan, L Zhao, X Lu, et al.
Bioorganic & Medicinal Chemistry|June 27, 2001
A new aspect of view in synthesizing new type beta-adrenoceptor blockers with ancillary antioxidant activitiesY C Huang, B N Wu, J L Yeh, et al.
Blood|February 15, 1997
Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemiaA Choudhury, J L Gajewski, J C Liang, et al.
Radiation Protection Dosimetry|May 8, 2015
Development of calibration facility for radon and its progenies at NIM (China)J C Liang, P H Zheng, Z J Yang, et al.
Leukemia & Lymphoma|June 5, 1998
Chromosome breaks and sister chromatid exchange as predictors of second cancers in Hodgkin's diseaseS S Strom, Y Gu, A J Sigurdson, et al.
Genes, Chromosomes & Cancer|January 1, 1994
Trisomy 7: a potential cytogenetic marker of human prostate cancer progressionM G Bandyk, L Zhao, P Troncoso, et al.
General Pharmacology|August 3, 2001
Pharmacological effects of an aldehyde type alpha/beta-adrenoceptor blocking agent with vasodilating propertiesC C Chiu, Y T Lin, C H Tsai, et al.
International Journal of Immunopathology and Pharmacology|June 11, 2011
Eugenolol and glyceryl-isoeugenol suppress LPS-induced iNOS expression by down-regulating NF-kappaB AND AP-1 through inhibition of MAPKS and AKT/IkappaBalpha signaling pathways in macrophagesJ L Yeh, J H Hsu, Y S Hong, et al.
Leukemia & Lymphoma|April 1, 1993
A new chemotherapy regimen for treatment of Hodgkin's disease associated with minimal genotoxicityJ C Liang, N M Bailey, G J Gabriel, et al.
Journal of Cardiovascular Pharmacology|January 12, 2000
Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activitiesJ L Yeh, S F Liou, J C Liang, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Cancer Genetics and Cytogenetics|May 1, 1994
5q- chromosome. Evidence for complex interstitial breaks in a case of refractory anemia with excess blastsL Nagarajan, L Zhao, X Lu, et al.
Bioorganic & Medicinal Chemistry|June 27, 2001
A new aspect of view in synthesizing new type beta-adrenoceptor blockers with ancillary antioxidant activitiesY C Huang, B N Wu, J L Yeh, et al.
Blood|February 15, 1997
Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemiaA Choudhury, J L Gajewski, J C Liang, et al.
Radiation Protection Dosimetry|May 8, 2015
Development of calibration facility for radon and its progenies at NIM (China)J C Liang, P H Zheng, Z J Yang, et al.
Leukemia & Lymphoma|June 5, 1998
Chromosome breaks and sister chromatid exchange as predictors of second cancers in Hodgkin's diseaseS S Strom, Y Gu, A J Sigurdson, et al.
Genes, Chromosomes & Cancer|January 1, 1994
Trisomy 7: a potential cytogenetic marker of human prostate cancer progressionM G Bandyk, L Zhao, P Troncoso, et al.
General Pharmacology|August 3, 2001
Pharmacological effects of an aldehyde type alpha/beta-adrenoceptor blocking agent with vasodilating propertiesC C Chiu, Y T Lin, C H Tsai, et al.
International Journal of Immunopathology and Pharmacology|June 11, 2011
Eugenolol and glyceryl-isoeugenol suppress LPS-induced iNOS expression by down-regulating NF-kappaB AND AP-1 through inhibition of MAPKS and AKT/IkappaBalpha signaling pathways in macrophagesJ L Yeh, J H Hsu, Y S Hong, et al.
Leukemia & Lymphoma|April 1, 1993
A new chemotherapy regimen for treatment of Hodgkin's disease associated with minimal genotoxicityJ C Liang, N M Bailey, G J Gabriel, et al.
Journal of Cardiovascular Pharmacology|January 12, 2000
Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activitiesJ L Yeh, S F Liou, J C Liang, et al.
Pageof 7